Overexpression of G protein-coupled receptor GPR87 promotes pancreatic cancer aggressiveness and activates NF-κB signaling pathway

Abstract

BackgroundPancreatic cancer is a highly lethal disease and has the worst prognosis of any major malignancy. G protein-coupled receptor GPR87 is reported to be overexpressed in multiple cancers. The clinical significance and biological role of GPR87 in pancreatic cancer, however, remain to be established.MethodsGPR87 expression in pancreatic cancer cell lines, paired patient tissues were determined using western blotting and Real-time PCR. Ninety-six human pancreatic cancer tissue samples were analyzed by immunochemistry (IHC) to investigate the association between GPR87 expression and the clinicopathological characteristics of pancreatic cancer. Functional assays, such as anchorage-independent growth, chicken chorioallantoic membrane (CAM) assay, transwell matrix penetration assay, and Annexin V-FITC and PI staining and a xenograft tumor model were used to determine the oncogenic role of GPR87 in human pancreatic cancer progression. The effect of GPR87 on NF-κB signaling pathway was further investigated using the luciferase reporter assays, and by detection of the NF-κB signaling downstream genes.ResultsHerein, we reported that GPR87 was markedly overexpressed in pancreatic cancer cells and clinical tissues. Immunohistochemical analysis showed that the expression of GPR87 significantly correlated with patients’ clinicopathologic features, including clinical stage and tumor-nodule-metastasis (TNM) classification. Pancreatic cancer patients with higher levels of GPR87 expression had shorter overall survival compared to patients with lower GPR87 levels. We gained valuable insights into the mechanism of GPR87 expression in pancreatic cancer cells by demonstrating that overexpressing GPR87 significantly enhanced, whereas silencing endogenous GPR87 inhibited, the proliferation, angiogenesis and increased resistance to gemcitabine-induced apoptosis of pancreatic cancer in vitro and tumorigenicity of pancreatic cancer cells in vivo. Finally, we demonstrated that GPR87 enhanced pancreatic cancer aggressiveness by activating NF-κB signaling pathway. Conclusions: Taken together, these findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy.ConclusionsOur findings suggest that GPR87 plays a critical oncogenic role in pancreatic cancer progression and highlight its potential as a target for pancreatic cancer therapy.Electronic supplementary materialThe online version of this article (doi:10.1186/s12943-017-0627-6) contains supplementary material, which is available to authorized users.

A fast genetically encoded fluorescent sensor for faithfulin vivoacetylcholine detection in mice, fish, worms and flies

“…GPCRs also have excellent specificity relative to other endogenous molecules (in this case ACh relative to choline), whereas PBPs often must be tuned by protein engineering (our scaffold protein initially had tighter affinity for choline than ACh). However, GPCRs can be difficult to overexpress, can cause problems when they are 21,22 , and are more difficult to target to organelles than soluble PBPs. Furthermore, GPCRs and other receptors contain many specific localization/export/retention/binding sequences (e.g.…”

“…Moreover, the sensor responds (positively or negatively) to all molecules that normally bind the M3 receptor, precluding the use of GACh2.0 in combination with many cholinergic drugs. Finally, over-expression of GPCRs perturbs the function of endogenous proteins such as G-proteins 21,22 and can disrupt cellular behavior 23 , creating concerns that GACh2.0-expressing cells may have altered ACh and/or other signaling pathways.…”

Loss of Fezf2 promotes malignant progression of bladder cancer by regulating the NF-κB signaling pathway

“…Previous studies have shown that the NF-κB signaling pathway not only plays a pivotal role in immune and inflammatory responses, but is also essential for tumorigenesis [14,15]. Specific targeting of the NF-κB signaling pathway has been intensively explored for its potential as a treatment for a variety of malignancies [16,17].…”

A Pan-cancer analysis of GPR183 correlated with tumor immunity

“…Aberrant regulation or mutations of GPRs, G proteins and downstream siganllings are implicated with various diseases such as heart failure [3], asthma [4] and bipolar disorder [5]. In addition, increasing evidences have pointed to GPRs and their downstream signallings as relevant players in cancer initiation and progression [6][7][8]. GPRs have been proved to play multiple roles in cell differentiation, cell proliferation, immune responses, invasion, angiogenesis and metastasis [7,9,10].…”

“…In addition, increasing evidences have pointed to GPRs and their downstream signallings as relevant players in cancer initiation and progression [6][7][8]. GPRs have been proved to play multiple roles in cell differentiation, cell proliferation, immune responses, invasion, angiogenesis and metastasis [7,9,10]. Thus, drugs targeted to GPRs for cancer prevention and treatment become promising.…”